These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus. Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951 [TBL] [Abstract][Full Text] [Related]
9. Occurrence and protective level of influenza infections using serology in patients with COPD in vaccination study. Kositanont U; Kanyok R; Wasi C; Wongsurakiat P; Suthamsmai T; Maranetra N J Med Assoc Thai; 2004 Aug; 87(8):964-9. PubMed ID: 15471303 [TBL] [Abstract][Full Text] [Related]
10. Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma. Zuccotti G; Amendola A; Viganò A; Pariani E; Zappa A; Pogliani L; Giacomet V; Savarino A; Podestà A; Rottoli A; Tanzi E; Zanetti A; Radaelli G Vaccine; 2007 Sep; 25(37-38):6692-8. PubMed ID: 17697730 [TBL] [Abstract][Full Text] [Related]
11. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in kidney transplant recipients. Lindemann M; Witzke O; Lütkes P; Fiedler M; Kreuzfelder E; Philipp T; Roggendorf M; Grosse-Wilde H Clin Immunol; 2006 Sep; 120(3):342-8. PubMed ID: 16631409 [TBL] [Abstract][Full Text] [Related]
12. Immune response after influenza vaccination in children with cancer. Matsuzaki A; Suminoe A; Koga Y; Kinukawa N; Kusuhara K; Hara T Pediatr Blood Cancer; 2005 Nov; 45(6):831-7. PubMed ID: 16007602 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Scharpé J; Peetermans WE; Vanwalleghem J; Maes B; Bammens B; Claes K; Osterhaus AD; Vanrenterghem Y; Evenepoel P Am J Kidney Dis; 2009 Jul; 54(1):77-85. PubMed ID: 19339089 [TBL] [Abstract][Full Text] [Related]
14. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL; Yogev R; Hayden FG; Ambrose CS; Zeng W; Walker RE Vaccine; 2008 Sep; 26(38):4940-6. PubMed ID: 18662737 [TBL] [Abstract][Full Text] [Related]
15. Dose sparing strategy with intradermal influenza vaccination in patients with solid cancer. Jo YM; Song JY; Hwang IS; Lee J; Oh SC; Kim JS; Kim SR; Kim WJ; Cheong HJ J Med Virol; 2009 Apr; 81(4):722-7. PubMed ID: 19235853 [TBL] [Abstract][Full Text] [Related]
17. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine]. Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Chiu SS; Peiris JS; Chan KH; Wong WH; Lau YL Pediatrics; 2007 Jun; 119(6):1076-82. PubMed ID: 17545373 [TBL] [Abstract][Full Text] [Related]
19. [Simultaneous vaccination against influenza and invasive pneumococcal disease in chronic dialysis patients]. Trmal J; Havlícková M; Bícová R; Bitterová Z; Kelerová J Epidemiol Mikrobiol Imunol; 2005 Aug; 54(3):123-8. PubMed ID: 16173523 [TBL] [Abstract][Full Text] [Related]
20. Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years. Nabeshima S; Kashiwagi K; Murata M; Kanamoto Y; Furusyo N; Hayashi J J Med Virol; 2007 Mar; 79(3):320-5. PubMed ID: 17245715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]